Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment

    1 week ago

    With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
    Click here to Read More
    Previous Article
    Tale Of 3 Gogois: How Congress Is Hoping To Script Return To Power In Assam
    Next Article
    In Tanvi Sharma’s Orleans Masters semifinal defeat against Nozomi Okuhara, lessons to be learnt for the promising teenager

    Related Breaking News Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment